Hypertension may affect tooth-supporting alveolar bone quality: A study in rats

Journal of Periodontology

Volumn 81, Issue 7, 2010, Pages 1075-1083

  Bastos, Marta Ferreira ^a,d   Brilhante, Felipe Vilhena ^a   Gonçalves, Tiago Eduardo Dias ^a   Pires, Amanda Gonçalves ^a   Napimoga, Marcelo Henrique ^b   Marques, Marcelo Rocha ^c   Duarte, Poliana Mendes ^a  

^a GUARULHOS UNIVERSITY   (Brazil)

^b UNIVERSITY OF UBERABA   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d Centro Guarulhos   (Brazil)

Author keywords

Alveolar bone loss; Hypertension; RANK ligand; Rats; Tartrate resistant acid phosphatase

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; DIHYDROPYRIDINE DERIVATIVE; ISOENZYME; LERCANIDIPINE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TARTRATE-RESISTANT ACID PHOSPHATASE;

ALVEOLAR BONE LOSS; ANIMAL; ARTICLE; BONE DENSITY; COMPARATIVE STUDY; DRUG EFFECT; HYPERTENSION; IMMUNOHISTOCHEMISTRY; JAW; MALE; MOLAR TOOTH; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TOOTH ROOT; WISTAR RAT;

ACID PHOSPHATASE; ALVEOLAR BONE LOSS; ALVEOLAR PROCESS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BONE DENSITY; DIHYDROPYRIDINES; HYPERTENSION; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MOLAR; OSTEOPROTEGERIN; RANK LIGAND; RATS; RATS, INBRED SHR; RATS, WISTAR; TOOTH ROOT;

EID: 77954524037     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2010.090705     Document Type: Article

References (42)

1. Johnson RJ, Feig DI, Nakagawa T, Sanchez-Lozada LG, Rodriguez-Iturbe B. Pathogenesis of essential hypertension: Historical paradigms and modern insights. J Hypertens 2008;26:381-391.
2. Izawa Y, Sagara K, Kadota T, Makita T. Bone disorders in spontaneously hypertensive rat. Calcif Tissue Int 1985;37:605-607.
3. Liang H, Ma Y, Pun S, Stimpel M, Jee W.S. Aging- and ovariectomy-related skeletal changes in spontaneously hypertensive rats. Anat Rec 1997;249:173-180.
4. Wright GL, DeMoss D. Evidence for dramatically increased bone turnover in spontaneously hypertensive rats. Metabolism 2000;49:1130-1133.
5. Gotoh M, Mizuno K, Ono Y, Takahashi M. High blood pressure, bone-mineral loss and insulin resistance in women. Hypertens Res 2005;28:565-570.
6. Mussolino ME, Gillum R.F. Bone mineral density and hypertension prevalence in postmenopausal women: Results from the Third National Health and Nutrition Examination Survey. Ann Epidemiol 2006;16:395-399.
7. Vestergaard P, Rejnmark L, Mosekilde L. Hypertension is a risk factor for fractures. Calcif Tissue Int 2009;84: 103-111.
8. McCarron DA, Pingree PA, Rubin RJ, Gaucher SM, Molitch M, Krutzik S. Enhanced parathyroid function in essential hypertension: A homeostatic response to a urinary calcium leak. Hypertension 1980;2:162-168.
9. Strazzullo P, Trevisan M, Farinaro E, et al. Characteristics of the association between salt intake and blood pressure in a sample of male working population in southern Italy. Eur Heart J 1983;4:608-613.
10. Young EW, McCarron DA, Morris C.D. Calcium regulating hormones in essential hypertension. Importance of gender. Am J Hypertens 1990;3:161S-166S.
11. Nakagami H, Morishita R. Hormones and osteoporosis update. Effect of angiotensin II on bone metabolism. Clin Calcium 2009;19:997-1002.
12. Arendt DM, Elzay R.P. Radiographic analysis of periodontal bone loss in hypertensive and normotensive patients. Va Dent J 1976;53:15-19.
13. Perlstein MI, Bissada N.F. Influence of obesity and hypertension on the severity of periodontitis in rats. Oral Surg Oral Med Oral Pathol 1977;43:707-719.
14. Angeli F, Verdecchia P, Pellegrino C, et al. Association between periodontal disease and left ventricle mass in essential hypertension. Hypertension 2003;41:488-492.
15. Holmlund A, Holm G, Lind L. Severity of periodontal disease and number of remaining teeth are related to the prevalence of myocardial infarction and hypertension in a study based on 4,254 subjects. J Periodontol 2006;77:1173-1178.
16. Leite CL, Redins CA, Vasquez EC, Meyrelles S.S. Experimental-induced periodontitis is exacerbated in spontaneously hypertensive rats. Clin Exp Hypertens 2005;27:523-531.
17. Al-Emadi A, Bissada N, Farah C, Siegel B, Al-Zaharani M. Systemic diseases among patients with and without alveolar bone loss. Quintessence Int 2006;37:761-765.
18. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco R.J. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000;71:1554-1560.
19. De Nardin E. The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease. Ann Periodontol 2001;6:30-40.
20. Beck JD, Offenbacher S. Systemic effects of periodontitis: Epidemiology of periodontal disease and cardiovascular disease. J Periodontol 2005;76(Suppl.): 2089-2100.
21. Boos CJ, Lip G.Y. Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: A relationship between inflammation and hypertension? J Hum Hypertens 2005;19:511-513.
22. Vidal F, Figueredo CM, Cordovil I, Fischer R.G. Periodontal therapy reduces plasma levels of interleukin- 6, C-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. J Periodontol 2009;80:786-791.
23. Castelli WA, Diaz-Perez R, Nasjleti CE, Caffesse R.G. Effect of renovascular hypertension on the morphology of oral blood vessels. Oral Surg Oral Med Oral Pathol 1978;46:576-582.
24. Sabbatini M, Vitaioli L, Baldoni E, Amenta F. Nephroprotective effect of treatment with calcium channel blockers in spontaneously hypertensive rats. J Pharmacol Exp Ther 2000;294:948-954. (Pubitemid 30666845)
25. Cole AA, Walters L.M. Tartrate-resistant acid phosphatase in bone and cartilage following decalcification and cold-embedding in plastic. J Histochem Cytochem 1987;35:203-206.
26. Trippodo NC, Frohlich E.D. Similarities of genetic (spontaneous) hypertension. Man and rat. Circ Res 1981;48:309-319.
27. Borghi C. Lercanidipine in hypertension. Vasc Health Risk Manag 2005;1:173-182.
28. Makarounas-Kirchmann K, Glover-Koudounas S, Ferrari P. Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers. Clin Ther 2009;31:1652-1663.
29. Nishiya Y, Sugimoto S. Effects of various antihypertensive drugs on the function of osteoblast. Biol Pharm Bull 2001;24:628-633.
30. Metz JA, Karanja N, Young EW, Morris CD, McCarron D.A. Bone mineral density in spontaneoushypertension: Differential effects of dietary calcium and sodium. Am J Med Sci 1990;300:225-230.
31. Wang TM, Hsu JF, Jee WS, Matthews J.L. Evidence for reduced cancellous bone mass in the spontaneously hypertensive rat. Bone Miner 1993;20:251-264.
32. Wright HL, McCarthy HS, Middleton J, Marshall M.J. RANK, RANKL and osteoprotegerin in bone biology and disease. Curr Rev Musculoskelet Med 2009;2:56-64.
33. Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Väänä nen H.K. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clin Lab 2006;52:499-509.
34. Barbagallo M, Raddino R, Restori G, Boiardi L, Novo S, Strano A. Alterations of calcium metabolism in spontaneously hypertensive rats. Cardioscience 1990;1: 105-107.
35. Barbagallo M, Quaini F, Baroni MC, et al. Histological evidence of increased turnover in bone from spontaneously hypertensive rats. Cardioscience 1991;2:15-17.
36. Inoue T, Moriya A, Goto K, Tanaka T, Inazu M. What is the difference of bone growth in SHR and SD rats? Clin Exp Pharmacol Physiol Suppl 1995;22:S242-S243.
37. Cappuccio FP, Meilahn E, Zmuda JM, Cauley J.A. High blood pressure and bone-mineral loss in elderly white women: A prospective study. Study of Osteoporotic Fractures Research Group. Lancet 1999;354:971-975.
38. Tsuda K, Nishio I, Masuyama Y. Bone mineral density in women with essential hypertension. Am J Hypertens 2001;14:704-707.
39. Hatton R, Stimpel M, Chambers T.J. Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro. J Endocrinol 1997;152:5-10.
40. Hagiwara H, Hiruma Y, Inoue A, Yamaguchi A, Hirose S. Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells. J Endocrinol 1998;156:543-550.
41. Shimizu H, Nakagami H, Osako MK, et al. Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 2008;22:2465-2475.
42. Gonçalves PF, Nogueira Filho GR, Sallum EA, Sallum AW, Nociti Júnior F.H. Immunosuppressant therapy and bone loss in ligature-induced periodontitis - A study in rats. Pesqui Odontol Bras 2003;17:46-50.